Placebo for antibiotic

DIETARY_SUPPLEMENT2 trials

Sponsors

University Hospital Tuebingen, Parker Institute for Cancer Immunotherapy

Conditions

Metastatic MelanomaSocial Stress

Phase 1

Melanoma Checkpoint and Gut Microbiome Alteration With Microbiome Intervention

CompletedNCT03817125

Parker Institute for Cancer ImmunotherapyMetastatic Melanoma

Start: 2019-01-28End: 2022-03-04Updated: 2024-06-06

Phase 2

Effect of Probiotics on Central Nervous System Functions in Humans

CompletedNCT02793193

University Hospital TuebingenSocial Stress

Start: 2016-07-31End: 2018-01-31Updated: 2020-11-02

Related Papers

Abstract CT030: Randomized placebo-controlled, biomarker-stratified phase 1b microbiome modulation trial for metastatic melanoma demonstrates impact of antibiotic pre-conditioning regimen on the microbiome and immunity

Cancer Research2024-04-05

Randomized Placebo-Controlled, Biomarker-Stratified Phase Ib Microbiome Modulation in Melanoma: Impact of Antibiotic Preconditioning on Microbiome and Immunity

Cancer Discovery2024-04-0353 citations

607 MCGRAW trial: evaluation of the safety and efficacy of an oral microbiome intervention (SER-401) in combination with nivolumab in first line metastatic melanoma patients

Regular and Young Investigator Award Abstracts2022-11-0110 citations

Effects of Rifaximin on Central Responses to Social Stress-a Pilot Experiment.

2018-07-0116 citations